Journals / Turkish Journal of Veterinary and Animal Sciences / 2014 / Cilt: 38 - Sayı: 6

Investigation of the effcacy of Tarantula cubensis extract (Teranekron D6) in the treatment of subclinical and clinical mastitis in dairy cows

Pages
712–718
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study demonstrated that Teranekron D6 could beused as an alternative therapeutic for the treatment of clinical and subclinical mastitis, as it is authorized for the use in cattle with awithdrawal period of zero hours for meat and milk.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to investigate the effects of the use of Teranekron alone or in combination with intramammaryantibiotic therapy for the treatment of subclinical and clinical mastitis on the recovery rate from mastitis.
📊
Key Findings & Data:The study material wascomposed of 177 mammary lobes of 63 Holstein cows with subclinical (groups S1 and S2) and clinical mastitis (groups C1, C2, C3,and C4).
💡
Conclusion & Impact:This study demonstrated that Teranekron D6 could beused as an alternative therapeutic for the treatment of clinical and subclinical mastitis, as it is authorized for the use in cattle with awithdrawal period of zero hours for meat and milk.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study was to investigate the effects of the use of Teranekron alone or in combination with intramammaryantibiotic therapy for the treatment of subclinical and clinical mastitis on the recovery rate from mastitis. The study material wascomposed of 177 mammary lobes of 63 Holstein cows with subclinical (groups S1 and S2) and clinical mastitis (groups C1, C2, C3,and C4). In all of the treatment groups, excluding group S2, the California mastitis test scores were determined to have decreased afertreatment (P 0.05), which was treated with Teranekron alone, the same values were found to haveincreased in group S2, which was maintained for control purposes (P < 0.05). This study demonstrated that Teranekron D6 could beused as an alternative therapeutic for the treatment of clinical and subclinical mastitis, as it is authorized for the use in cattle with awithdrawal period of zero hours for meat and milk.

🔖

Cite This Article

CANOOĞLU, E., ABAY, M., GÜRBULAK, K., AKÇAY, A., BEKYÜREK, T., SIST, B., STEINER, S., GÜMÜŞSOY, K. S. (2022). Investigation of the effcacy of Tarantula cubensis extract (Teranekron D6) in the treatment of subclinical and clinical mastitis in dairy cows. Turkish Journal of Veterinary and Animal Sciences, Cilt: 38 - Sayı: 6, 712–718. https://ajindex.com/articles/615269

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Seegers H, Fourichon C, Beaudeau F. Production efects related to mastitis and mastitis economics in dairy cattle herds. Vet Res 2003; 34: 475–491
  2. Janzen JJ. Economic losses resulting from mastitis. A review. J Dairy Sci 1970; 53: 1151–1161
  3. Sandholm M, Matilla T. Biochemical aspects of bovine mastitis. Isr J Vet Med 1986; 42: 405–415
  4. Sears PM, Heider LE. Detection of mastitis. Vet Clin North Am Large Anim Pract 1981; 3: 327–346. 5. de Haas Y, Barkema HW, Schukken YF, Veerkamp RF. Associations between somatic cell count patterns and the incidence of clinical mastitis. Prev Vet Med 2005; 67: 55–68
  5. Ziv G. Treatment of peracute and acute mastitis. Vet Clin North Am Food Anim Pract 1992; 8: 1–15
  6. Jones GF, Ward GE. Cause, occurrence, and clinical signs of mastitis and anorexia in cows in a Wisconsin study. J Am Vet Med Assoc 1989; 195: 1108–1113
  7. Quinn PJ, Carter ME, Markey BK, Carter GR. Clinical Veterinary Microbiology. London, UK: Wolfe Publishing; 1994
  8. Erskine RJ, Kirk JH, Tyler JW, DeGraves FJ. Advances in the therapy for mastitis. Vet Clin North Am Food Animal Pract 1993; 9: 499–517
  9. Nair MK, Joy J, Vasudevan P, Hinckley L, Hoagland TA, Venkitanarayanan KS. Antibacterial efect of caprylic acid and monocaprylin on major bacterial mastitis pathogens. J Dairy Sci 2005; 88: 3488–3495
  10. Diarra MS, Petitclerc D, Lacasse P. Response of Staphylococcus aureus isolates from bovine mastitis to exogenous iron sources. J Dairy Sci 2002; 85: 2141–2148
  11. Oldham ER, Daley MJ. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic. J Dairy Sci 1991; 74: 4175–4182
  12. Hillerton JE, Semmens JE. Comparison of treatment of mastitis by oxytocin or antibiotics following detection according to changes in milk electrical conductivity prior to visible signs J Dairy Sci. 1999; 82: 93–98.